Article
P1 and P2' site mutations convert protease nexin-2 from a factor XIa inhibitor to a plasmin inhibitor.
Journal of biochemistry - 1 Feb 2013
Navaneetham Duraiswamy, Wu Wenman, Li Hongbo, Sinha Dipali, Tuma Ronald F, Walsh Peter N
Abstract excerpt
The kunitz protease inhibitor domain of PN2 (PN2KPI) is a potent and specific inhibitor (K(i) 0.5-2 nM) of factor XIa (FXIa) and inhibits cerebrovascular thrombosis in mice. To determine whether the antithrombotic properties of PN2KPI arise from its FXIa-inhibitory activity, we have now prepared mutant forms of PN2KPI. Mutations at the P1 (Arg(15)) site in combination with P2' (Met(17)) mutations profoundly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
